1000 resultados para 17-hydroxyprogesterone
Resumo:
Para se conhecer a ação de misturas de alachlor com diuron ou com cyanazine para o controle de monotiledôneas e de dicotiledôneas em cultura de algodão 'IAC-17', foi conduzido um experimento de campo, em 1981/82, em Mogi-Mirim, SP, em solo com textura areno-argilosa, onde alachlor a 2,15 kg, 2,58 kg e 3,01 kg/ha foi aplicado em mistura de tanque com diuron, a 1,00 kg/ha ou com cyanazine a 1,00 kg/ha. Os herbicidas que compuseram as misturas foram empregados isoladamente, naquelas mesmas doses. Constaram do experimento ainda, duas testemunhas mantidas sem mato por meio de capinas e uma testemunha sem capina. Os 14 tratamentos foram distribuídos em blocos ao acaso, com quatro repetições. Foram realizadas observações visuais de infestação de mato aos 14, 31, 45, 75, 82, 94 e 100 dias após a aplicação dos herbicidas. Quando, pelo menos, uma parcela do tratamento atingia 25% de reinfestação, todo o tratamento era capinado e mantido no limpo até a colheita. Foram consideradas também a altura das plantas, sua população e a produção do algodão em caroço. Os resultados obtidos mostram que alachlor a 3,01 kg/ha + diuron a 1,00 kg/ha conseguiram bons resultados de controle das plantas daninhas por período de 100 dias enquanto que alachlor a 2,58 kg/ha + diuron a 1,00 kg/ha, e alachlor a 2,58 kg/ha e a 3,01 kg/ha + cyanazine a 1,00 kg/ha persistiram com sua ação de controle por 94 dias. Os tratamentos com alachlor a 3,01 kg/ha, diuron a 1,00 kg/ha, alachlor a 2,15 kg, 2,58 kg e 3,01 kg/ha em mistura com diuron a 1,00 kg/ha, e ainda alachlor a 3,01 kg/ha + cyanazine a 1,00 kg/ha, apresentaram tendências a reduzir a altura das plantas, segundo resultados de suas análises pelo teste de Tukey a 5%, sendo que a testemunha sem capina apresentou altura significativamente inferior aos demais tratamentos. A população e a produção não foram influenciadas pelos tratamentos com herbicidas, sendo semelhantes à testemunha capinada e superiores à testemunha sem capina.
Resumo:
No ano agríco la de 1978/79 instalou-se um ensaio na área experimental da Escola Superior de Agricultura "Luiz de Queiroz", USP, em Piracicaba, SP, tendo por objetivo estudar os efeitos de reguladores vegetais, em diferentes doses e épocas de aplicação, sobre a cultura do algodoeiro (Gossypium hirsutum L. ). Os tratamentos utilizados foram: cloreto de mepiquat (DPC) nas concentrações de 84, 167 e 250ppm, cloreto de clorocolina (CCC) nas dosagens de 250, 380 e 450ppm e ethephon (CEPA) nas concentrações 1670, 3340 e 6880ppm, sendo cada substância aplicada 51, 65 e 143 dias após a germinação, respectivamente. CCC e DPC tornaram mais compacta a arquitetura das plantas de algodoeiro, assim como promoveram reduções nos parâmetros da análise de crescimento. O número de ramos produtivos e de maçãs não foi afetado por esses reguladores. Foram notadas algumas variações nos parâmetros de produtividade, sendo que CCC, DPC e CEPA tenderam a aumentar o peso médio de algodão por planta . Esses produtos não depreciaram os caracteres agronômicos do algodão, nem as características tecnológicas.
Resumo:
Soitinnus: piano.
Resumo:
Tutkielmassa selvitetään IAS 17 -standardin mahdollisen muutoksen vaikutuksia pörssiyhtiöiden kirjanpitoon. IAS 17 on vuokrien kirjanpitoa koskeva standardi.
Resumo:
The incidence of TP53 point mutations and loss of heterozygosity (LOH) of chromosome 17 in colorectal tumors was determined in a group of Brazilian patients. We screened DNA samples from tumors and distal normal mucosa of 39 patients with colorectal cancer, for TP53 mutations by PCR-SSCP (single-strand conformation polymorphism) analysis. Chromosome 17 LOH was investigated using six PCR-based polymorphic markers and one VNTR probe. TP53 mutations were demonstrated in 15/39 of the cases. Mutations were distributed among all exons examined (five to eight), the majority of them being G/C to A/T transitions. LOH of chromosome 17p and 17q was detected in 70 and 46% of the tumors, respectively. There was a significant association between TP53 mutations and LOH in chromosome 17p (P = 0.0035) and 17q (P = 0.03). Although no correlation was observed between TP53 genetic alterations and clinical/ pathological characteristics, the association of TP53 mutations with loss of both chromosome 17 arms may indicate that TP53 inactivation provokes an unstable phenotype in tumor cells in colorectal tumors.
Resumo:
The present study evaluated the short-term effects of percutaneous 17ß-estradiol on blood pressure, metabolic profile and hormonal levels in postmenopausal women with systemic arterial hypertension. After a wash-out period of 15 days, 10 hypertensive patients were treated with guanabenz acetate to control blood pressure, followed by 17ß-estradiol in the form of hydroalcoholic gel administered for 21 of 28 days of each cycle, for 3 cycles. Patients were evaluated before, during and 2 months after estrogen administration. Systolic and diastolic blood pressure or heart rate did not present any significant change in any patient when compared to those periods with the antihypertensive drug only (pretreatment period and 60 days after estrogen therapy was discontinued). Plasma biological markers of hepatic estrogenic action (plasma renin activity, antithrombin III, triglycerides, total cholesterol and lipoproteins) also remained unchanged during the study. Hormone treatment was effective, as indicated by the relief of menopausal symptoms, a decrease in FSH levels (73.48 ± 27.21 to 35.09 ± 20.44 IU/l, P<0.05), and an increase in estradiol levels (15.06 ± 8.76 to 78.7 ± 44.6 pg/ml, P<0.05). There was no effect on LH (18.0 ± 9.5 to 14.05 ± 8.28 IU/l). Hormone levels returned to previous values after estrogen treatment was discontinued. The data indicate that short-term percutaneous 17ß-estradiol replacement therapy, at the dose used, seems to be a safe hormone therapy for hypertensive menopausal women. Nevertheless, a controlled, prospective, randomized clinical assay with a larger number of subjects is needed to definitely establish both the beneficial and harmful effects of hormone replacement therapy in hypertensive women
Resumo:
We studied the distribution of NADPH-diaphorase activity in the visual cortex of normal adult New World monkeys (Saimiri sciureus) using the malic enzyme "indirect" method. NADPH-diaphorase neuropil activity had a heterogeneous distribution. In coronal sections, it had a clear laminar pattern that was coincident with Nissl-stained layers. In tangential sections, we observed blobs in supragranular layers of V1 and stripes throughout the entire V2. We quantified and compared the tangential distribution of NADPH-diaphorase and cytochrome oxidase blobs in adjacent sections of the supragranular layers of V1. Although their spatial distributions were rather similar, the two enzymes did not always overlap. The histochemical reaction also revealed two different types of stained cells: a slightly stained subpopulation and a subgroup of deeply stained neurons resembling a Golgi impregnation. These neurons were sparsely spined non-pyramidal cells. Their dendritic arbors were very well stained but their axons were not always evident. In the gray matter, heavily stained neurons showed different dendritic arbor morphologies. However, most of the strongly reactive cells lay in the subjacent white matter, where they presented a more homogenous morphology. Our results demonstrate that the pattern of NADPH-diaphorase activity is similar to that previously described in Old World monkeys
Resumo:
We studied the basal and thyrotropin-releasing hormone (TRH) (50 nM) induced thyrotropin (TSH) release in isolated hemipituitaries of ovariectomized rats treated with near-physiological or high doses of 17-ß-estradiol benzoate (EB; sc, daily for 10 days) or with vehicle (untreated control rats, OVX). One group was sham-operated (normal control). The anterior pituitary glands were incubated in Krebs-Ringer bicarbonate medium, pH 7.4, at 37oC in an atmosphere of 95% O2/5% CO2. Medium and pituitary TSH was measured by specific RIA (NIDDK-RP-3). Ovariectomy induced a decrease (P<0.05) in basal TSH release (normal control = 44.1 ± 7.2; OVX = 14.7 ± 3.0 ng/ml) and tended to reduce TRH-stimulated TSH release (normal control = 33.0 ± 8.1; OVX = 16.6 ± 2.4 ng/ml). The lowest dose of EB (0.7 µg/100 g body weight) did not reverse this alteration, but markedly increased the pituitary TSH content (0.6 ± 0.06 µg/hemipituitary; P<0.05) above that of OVX (0.4 ± 0.03 µg/hemipituitary) and normal rats (0.46 ± 0.03 µg/hemipituitary). The intermediate EB dose (1.4 µg/100 g body weight) induced a nonsignificant tendency to a higher TSH response to TRH compared to OVX and a lower response compared to normal rats. Conversely, in the rats treated with the highest dose (14 µg/100 g body weight), serum 17-ß-estradiol was 17 times higher than normal, and the basal and TRH-stimulated TSH release, as well as the pituitary TSH content, was significantly (P<0.05) reduced compared to normal rats and tended to be even lower than the values observed for the vehicle-treated OVX group, suggesting an inhibitory effect of hyperestrogenism. In conclusion, while reinforcing the concept of a positive physiological regulatory role of estradiol on the TSH response to TRH and on the pituitary stores of the hormone, the present results suggest an inhibitory effect of high levels of estrogen on these responses
Resumo:
Metric features and modular and laminar distributions of intrinsic projections of area 17 were studied in Cebus apella. Anterogradely and retrogradely labeled cell appendages were obtained using both saturated pellets and iontophoretic injections of biocytin into the operculum. Laminar and modular distributions of the labeled processes were analyzed using Nissl counterstaining, and/or cytochrome oxidase and/or NADPH-diaphorase histochemistry. We distinguished three labeled cell types: pyramidal, star pyramidal and stellate cells located in supragranular cortical layers (principally in layers IIIa, IIIb a, IIIb ß and IIIc). Three distinct axon terminal morphologies were found, i.e., Ia, Ib and II located in granular and supragranular layers. Both complete and partial segregation of group I axon terminals relative to the limits of the blobs of V1 were found. The results are compatible with recent evidence of incomplete segregation of visual information flow in V1 of Old and New World primates
Resumo:
Acute promyelocytic leukemia (AML M3) is a well-defined subtype of leukemia with specific and peculiar characteristics. Immediate identification of t(15;17) or the PML/RARA gene rearrangement is fundamental for treatment. The objective of the present study was to compare fluorescent in situ hybridization (FISH), reverse transcriptase-polymerase chain reaction (RT-PCR) and karyotyping in 18 samples (12 at diagnosis and 6 after treatment) from 13 AML M3 patients. Bone marrow samples were submitted to karyotype G-banding, FISH and RT-PCR. At diagnosis, cytogenetics was successful in 10 of 12 samples, 8 with t(15;17) and 2 without. FISH was positive in 11/12 cases (one had no cells for analysis) and positivity varied from 25 to 93% (mean: 56%). RT-PCR was done in 6/12 cases and all were positive. Four of 8 patients with t(15;17) presented positive RT-PCR as well as 2 without metaphases. The lack of RT-PCR results in the other samples was due to poor quality RNA. When the three tests were compared at diagnosis, karyotyping presented the translocation in 80% of the tested samples while FISH and RT-PCR showed the PML/RARA rearrangement in 100% of them. Of 6 samples evaluated after treatment, 3 showed a normal karyotype, 1 persistence of an abnormal clone and 2 no metaphases. FISH was negative in 4 samples studied and 2 had no material for analysis. RT-PCR was positive in 4 (2 of which showed negative FISH, indicating residual disease) and negative in 2. When the three tests were compared after treatment, they showed concordance in 2 of 6 samples or, when there were not enough cells for all tests, concordance between karyotype and RT-PCR in one. At remission, RT-PCR was the most sensitive test in detecting residual disease, as expected (positive in 4/6 samples). An incidence of about 40% of 5' breaks and 60% of 3' breaks, i.e., bcr3 and bcr1/bcr2, respectively, was observed.
Resumo:
The objective of the present study was to evaluate the effect of 17ß-estradiol or alendronate in preventing bone loss in 3-month-old ovariectomized Wistar rats. One group underwent sham ovariectomy (control, N = 10), and the remaining three underwent double ovariectomy. One ovariectomized group did not receive any treatment (OVX, N = 12). A second received subcutaneous 17ß-estradiol at a dose of 30 µg/kg for 6 weeks (OVX-E, N = 11) and a third, subcutaneous alendronate at a dose of 0.1 mg/kg for 6 weeks (OVX-A, N = 8). Histomorphometry, densitometry, osteocalcin and deoxypyridinoline measurements were applied to all groups. After 6 weeks there was a significant decrease in bone mineral density (BMD) at the trabecular site (distal femur) in OVX rats. Both alendronate and 17ß-estradiol increased the BMD of ovariectomized rats, with the BMD of the OVX-A group being higher than that of the OVX-E group. Histomorphometry of the distal femur showed a decrease in trabecular volume in the untreated group (OVX), and an increase in the two treated groups, principally in the alendronate group. In OVX-A there was a greater increase in trabecular number. An increase in trabecular thickness, however, was seen only in the OVX-E group. There was also a decrease in bone turnover in both OVX-E and OVX-A. The osteocalcin and deoxypyridinoline levels were decreased in both treated groups, mainly in OVX-A. Although both drugs were effective in inhibiting bone loss, alendronate proved to be more effective than estradiol at the doses used in increasing bone mass.
Resumo:
The present study was designed to determine relaxation in response to 17ß-estradiol by isolated perfused hearts from intact normotensive male and female rats as well as the contribution of endothelium and its relaxing factors to this action. Baseline coronary perfusion pressure was determined and the vasoactive effects of 17ß-estradiol (10 µM) were assessed by in bolus administration before and after endothelium denudation by infusion of 0.25 µM sodium deoxycholate or perfusion with 100 µM L-NAME, 2.8 µM indomethacin, 0.75 µM clotrimazole, 100 µM L-NAME plus 2.8 µM indomethacin, and 100 µM L-NAME plus 0.75 µM clotrimazole. Baseline coronary perfusion pressure differed significantly between males (84 ± 2 mmHg, N = 61) and females (102 ± 2 mmHg, N = 61). Bolus injection of 10 µM 17ß-estradiol elicited a transient relaxing response in all groups, which was greater in coronary beds from females. For both sexes, the relaxing response to 17ß-estradiol was at least in part endothelium-dependent. In the presence of the nitric oxide synthase inhibitor L-NAME, the relaxing response to 17ß-estradiol was reduced only in females. Nevertheless, in the presence of indomethacin, a cyclooxygenase inhibitor, or clotrimazole, a cytochrome P450 inhibitor, the 17ß-estradiol response was significantly reduced in both groups. In addition, combined treatment with L-NAME plus indomethacin or L-NAME plus clotrimazole also reduced the 17ß-estradiol response in both groups. These results indicate the importance of prostacyclin and endothelium-derived hyperpolarizing factor in the relaxing response to 17ß-estradiol. 17ß-estradiol-induced relaxation may play an important role in the regulation of coronary tone and this may be one of the reasons why estrogen replacement therapy reduces the risk of coronary heart disease in postmenopausal women.
Resumo:
International Accounting Standards Boardin (IASB) tavoitteena on julkistaa nykyisen IAS 17 Vuokrasopimukset -standardin korvaava uusi leasingstandardi vuoden 2015 loppuun mennessä. Tämän tutkimuksen tarkoituksena oli tutkia IAS 17 -standardimuutoksen vaikutuksia vuokralleottajayritysten näkökulmasta. Tutkimus rajattiin koskemaan vain vuokralle ottajia. IASB:n alustavien päätösten mukaan uudistuvan leasingstandardin merkittävimmät muutokset kohdistuisivat erityisesti vuokralle ottajiin. Tutkimuksen tavoitteena oli selvittää kaikkien yli 12 kuukauden leasingsopimusten taseaktivoinnin vaikutuksia vuokralle ottajiin sekä standardimuutoksen vaikutuksia vuokralle ottajien liiketoimintaan ja tilinpäätösraportointiin. Tutkimuksessa leasingstandardimuutoksen vaikutuksia tarkasteltiin ja vertailtiin myös eri toimialojen välillä. Tutkimus on laadullinen eli kvalitatiivinen tutkimus. Tutkimuksen empiirinen aineisto muodostuu eri tahojen lähettämistä kommenttikirjeistä International Accounting Standards Boardin (IASB) julkaisemaan viimeisimpään leasingstandardiluonnokseen, joka julkaistiin toukokuussa 2013. Tutkimuksen kokonaisaineisto muodostuu 641 kommenttikirjeestä, jotka ovat nähtävillä Financial Accounting Standards Boardin (FASB) kotisivuilla. Tämän tutkimuksen varsinaiseksi tutkimusaineistoksi rajattiin kokonaistutkimusaineistosta 65 vuokralle ottajien kommenttikirjettä. Tutkimustuloksissa suhtautuminen kaikkien yli 12 kuukauden leasingsopimusten aktivointiin vuokralle ottajien taseissa oli selkeästi enemmän negatiivinen kuin positiivinen. Toimialakohtaisia eroja standardimuutokseen suhtautumisessa oli myös havaittavissa. Tutkimustulosten perusteella vähittäismyynnin ja ruokakaupan toimialoihin tulisi kohdistumaan merkittävimmät vaikutukset standardimuutoksesta johtuen. Vuokralle ottajien liiketoiminnalle vaikutuksia aiheutuisi tutkimustulosten perusteella etenkin uuden standardin käyttöönoton kustannuksista ja kasvavasta hallinnollisesta taakasta.
Resumo:
Refractory hypotension is frequent in very low-birth weight infants, whose hypothalamic-pituitary-adrenal axis has been suggested to be immature. The objective of the present study was to evaluate basal cortisol and 17-a-OH-progesterone in the first 36 h of life in preterm infants with and without refractory hypotension (mean arterial blood pressure below the lower limit for gestational age throughout the study despite aggressive volume expansion and use of vasopressors). Thirty-five infants with £30 weeks of gestation and a birth weight £1250 g, with no postnatal use of corticosteroid or death in the first 48 h were studied. Mean arterial pressure was measured every 4 h during the first 48 h. Cortisol and 17-a-OH-progesterone were determined at 12 and 36 h and patients were divided into refractory hypotensive (N = 15) and control (N = 20) groups. The groups were not different regarding type of delivery, use of prenatal corticosteroid, requirement of mechanical ventilation, use of vasopressor drugs, morphine, fentanyl, prophylactic indomethacin, and mean sample timing. Although refractory hypotensive newborns were more immature, were smaller, suffered more deaths after 48 h of life and had a higher SNAPPE-2 score, their cortisol and 17-a-OH-progesterone levels were not different from controls at 12 h and at 36 h. The increase of cortisol in newborns with refractory hypotension 36 h after birth was significantly higher than in controls. Despite the fact that refractory hypotensive very low-birth weight neonates were submitted to a very stressful condition, their cortisol and 17-a-OH-progesterone levels were similar to controls.